Effects of Buprenorphine and naloxone (BEMA Buprenorphine NX) in opioid dependent subjects.

Trial Profile

Effects of Buprenorphine and naloxone (BEMA Buprenorphine NX) in opioid dependent subjects.

Withdrawn prior to enrolment
Phase of Trial: Phase III

Latest Information Update: 09 May 2017

At a glance

  • Drugs Buprenorphine/naloxone (Primary)
  • Indications Drug dependence
  • Focus Therapeutic Use
  • Sponsors BioDelivery Sciences International
  • Most Recent Events

    • 02 Feb 2015 Status changed from not yet recruiting to withdrawn prior to enrolment as reported by ClinicalTrials.gov record.
    • 04 Nov 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top